Woodline Partners’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-322,680
| Closed | -$558K | – | 614 |
|
|
2024
Q2 | $558K | Sell |
322,680
-212,759
| -40% | -$368K | 0.01% | 491 |
|
|
2024
Q1 | $1.28M | Buy |
535,439
+35,439
| +7% | +$84.7K | 0.01% | 445 |
|
|
2023
Q4 | $1.67M | Hold |
500,000
| – | – | 0.02% | 384 |
|
|
2023
Q3 | $1.87M | Hold |
500,000
| – | – | 0.02% | 403 |
|
|
2023
Q2 | $2.14M | Buy |
+500,000
| New | +$2.14M | 0.03% | 416 |
|